Literature DB >> 11089632

Lipodystrophy following antiretroviral therapy of primary HIV infection.

J Miller1, A Carr, D Smith, S Emery, M G Law, P Grey, D A Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11089632     DOI： 10.1097/00002030-200010200-00025

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

1.  Primary HIV-1 Infection: Diagnosis, Pathogenesis, and Treatment.

Authors:  Malini Soogoor; Eric S Daar
Journal:  Curr Infect Dis Rep       Date:  2005-03       Impact factor: 3.725

Review 2.  HIV-associated lipodystrophy: impact of antiretroviral therapy.

Authors:  Giovanni Guaraldi; Chiara Stentarelli; Stefano Zona; Antonella Santoro
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

3.  Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapy.

Authors:  Eugene Mutimura; Aimee Stewart; Paul Rheeder; Nigel John Crowther
Journal:  J Acquir Immune Defic Syndr       Date:  2007-12-01       Impact factor: 3.731

Review 4.  Primary HIV Infection.

Authors:  Joanne Stekler; Ann C Collier
Journal:  Curr HIV/AIDS Rep       Date:  2004-06       Impact factor: 5.495

5.  Treatment of Primary HIV.

Authors:  Joanne Stekler; Ann Collier
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.663
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.